| Item Number | Description | Schedule Fee |
|---|---|---|
| 73319 | Detection in tumour tissue of isocitrate dehydrogenase 1 (IDH1) variant status, in a patient with histologically confirmed cholangiocarcinoma, to determine eligibility for a relevant treatment listed under the Pharmaceutical Benefits Scheme. Applicable only once per lifetime |
$340.00 |
| Total: | $340.00 | |